Postprandial Glycemic Response of Glucomeal as Pre-meal (before breakfast) in Type 2 Diabetic Patients

Phase 1

Completed

• Conditions: Type 2 diabetes; T2DM

• Registration Number: TCTR20210429006
• Lead Sponsor: Mega Lifesciences Public Company Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-08-20
• Study Start: 2021-04-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

1.BMI 18.5-30 kg-m2
2.Only stable oral hypoglycemic drugs for at least 2 months.

Exclusion Criteria

1. Concomitant therapy insulin
2. Person with gastrointestinal disease, renal disease, liver disease, thyroid disease, cancer, cardiovascular disease
3. Pregnant or lactating females.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
postprandial glycemic control Before taking intervention meal (-30 min). And at 0, 30, 60, 90, 120, 180 and 240 minutes after consume. Blood glucose,postprandial insulin response Before taking intervention meal (-30 min). And at 0, 30, 60, 90, 120, 180 and 240 minutes after consume. Insulin

Secondary Outcome Measures

Name	Time	Method
postprandial active-GLP-1 response Before taking intervention meal (-30 min). And at 0, 30, 60, 90, 120, 180 and 240 minutes after consume. Active-GLP-1